LeMaitre to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Rhea-AI Summary
LeMaitre Vascular announced that CFO JJ Pellegrino will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:30 AM ET. The company specializes in devices and services for treating peripheral vascular disease, impacting over 200 million people globally. LeMaitre develops and markets both disposable and implantable vascular devices tailored for vascular surgeons. More information is available at www.lemaitre.com.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the trading session that priced this news, LMAT declined 1.29%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 16, 2022, at 10:30 AM ET.
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.